• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRYM2 通过氧化磷酸化直接调节复合物 I 活性以支持结直肠癌中的肿瘤生长。

LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation.

机构信息

Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China; Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, Hangzhou, 310009, China; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.

Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China; Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, Hangzhou, 310009, China.

出版信息

Cancer Lett. 2019 Jul 28;455:36-47. doi: 10.1016/j.canlet.2019.04.021. Epub 2019 Apr 17.

DOI:10.1016/j.canlet.2019.04.021
PMID:31004700
Abstract

Oxidative phosphorylation (OXPHOS) in cancer has attracted a considerable attention in the past decades, and accumulated evidence has suggested that it plays an important role in tumor proliferation, metastasis and drug resistance. However, the mechanisms involved in these effects are still ambiguous to date. In this study, we found that LYR motif containing 2 (LYRM2), a novel molecule, is up-regulated in colorectal cancer and promotes tumor growth both in vivo and in vitro. Furthermore, we discovered that LYRM2 locates in the mitochondria, directly interacts with complex I and increases its activity, thus promoting OXPHOS in colorectal cancer cells. More importantly, we identified a new Akt-S58phos-LYRM2-Complex I axis, which is responsible for the LYRM2-induced tumor growth and the activation of OXPHOS in colorectal cancer. Our finding illustrates the role of LYRM2 in regulating tumor metabolism and provides a new potential target for colorectal cancer treatment.

摘要

在过去的几十年中,癌症中的氧化磷酸化(OXPHOS)引起了相当大的关注,并且已有大量证据表明,它在肿瘤增殖、转移和耐药性中发挥重要作用。然而,迄今为止,这些作用涉及的机制仍不明确。在这项研究中,我们发现含有 LYR 基序的 2 型(LYRM2)是一种新型分子,在结直肠癌中上调,并促进体内和体外的肿瘤生长。此外,我们发现 LYRM2 位于线粒体中,直接与复合物 I 相互作用并增加其活性,从而促进结直肠癌细胞中的 OXPHOS。更重要的是,我们确定了一个新的 Akt-S58phos-LYRM2-Complex I 轴,该轴负责 LYRM2 诱导的肿瘤生长和结直肠癌细胞中 OXPHOS 的激活。我们的发现说明了 LYRM2 在调节肿瘤代谢中的作用,并为结直肠癌的治疗提供了一个新的潜在靶点。

相似文献

1
LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation.LRYM2 通过氧化磷酸化直接调节复合物 I 活性以支持结直肠癌中的肿瘤生长。
Cancer Lett. 2019 Jul 28;455:36-47. doi: 10.1016/j.canlet.2019.04.021. Epub 2019 Apr 17.
2
IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.IMPdh2 通过激活 PI3K/AKT/mTOR 和 PI3K/AKT/FOXO1 信号通路促进结直肠癌的进展。
J Exp Clin Cancer Res. 2018 Dec 5;37(1):304. doi: 10.1186/s13046-018-0980-3.
3
MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.微小RNA-587通过调节结直肠癌中PPP2R1B的表达来拮抗5-氟尿嘧啶诱导的细胞凋亡并赋予耐药性。
Cell Death Dis. 2015 Aug 6;6(8):e1845. doi: 10.1038/cddis.2015.200.
4
Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.肿瘤来源的CXCL5通过激活ERK/Elk-1/Snail和AKT/GSK3β/β-连环蛋白通路促进人类结直肠癌转移。
Mol Cancer. 2017 Mar 29;16(1):70. doi: 10.1186/s12943-017-0629-4.
5
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.致癌热休克蛋白 60 通过调节线粒体氧化磷酸化来支持胰腺癌生长过程中 Erk1/2 的激活。
Cell Death Dis. 2018 Feb 7;9(2):161. doi: 10.1038/s41419-017-0196-z.
6
HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.HPIP在结直肠癌中上调,并调节结直肠癌细胞的增殖、凋亡和侵袭。
Sci Rep. 2015 Mar 24;5:9429. doi: 10.1038/srep09429.
7
COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.COPS5 和 LASP1 协同相互作用,通过激活 PI3K/AKT 通路下调 14-3-3σ 的表达,促进结直肠癌的进展。
Int J Cancer. 2018 May 1;142(9):1853-1864. doi: 10.1002/ijc.31206. Epub 2017 Dec 27.
8
LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.LINC01296/miR-26a/GALNT3 轴通过 PI3K/AKT 通路调节 O-糖基化 MUC1 促进结直肠癌的进展。
J Exp Clin Cancer Res. 2018 Dec 14;37(1):316. doi: 10.1186/s13046-018-0994-x.
9
Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation.乳腺癌相关的线粒体 DNA 单倍群通过 ROS 介导的 AKT 激活促进肿瘤生长。
Int J Cancer. 2018 May 1;142(9):1786-1796. doi: 10.1002/ijc.31207. Epub 2017 Dec 20.
10
Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.新型六氢大麻酚类似物 LYR-8 在人结直肠肿瘤异种移植中的抗肿瘤活性是通过抑制 Akt 和缺氧诱导因子-1α 的激活来介导的。
Biol Pharm Bull. 2012;35(6):924-32. doi: 10.1248/bpb.35.924.

引用本文的文献

1
Clinical application prospects of traditional Chinese medicine as adjuvant therapy for metabolic reprogramming in colorectal cancer.中药作为辅助治疗手段在结直肠癌代谢重编程中的临床应用前景
Front Immunol. 2025 Jul 15;16:1630279. doi: 10.3389/fimmu.2025.1630279. eCollection 2025.
2
Structural and Functional Perspectives on Mitochondrial LYR-Domain Proteins in Plants.植物线粒体LYR结构域蛋白的结构与功能研究视角
Physiol Plant. 2025 Jul-Aug;177(4):e70393. doi: 10.1111/ppl.70393.
3
Mendelian Randomization Analysis of Mitochondria-Related Genes and Screening of Prognostic Genes in Colorectal Cancer.
结直肠癌中线粒体相关基因的孟德尔随机化分析及预后基因筛选
Cancer Med. 2025 Jul;14(13):e71012. doi: 10.1002/cam4.71012.
4
Single cell analysis reveals that SPP1 macrophages enhance tumor progression by triggering fibroblast extracellular vesicles.单细胞分析显示,SPP1巨噬细胞通过触发成纤维细胞外泌体来促进肿瘤进展。
Transl Oncol. 2025 May;55:102347. doi: 10.1016/j.tranon.2025.102347. Epub 2025 Mar 13.
5
Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines.利用结直肠癌类器官和细胞系中的基因表达生物标志物预测患者预后。
Front Mol Biosci. 2025 Jan 15;12:1531175. doi: 10.3389/fmolb.2025.1531175. eCollection 2025.
6
LYRM2 Promotes the Growth and Metastasis of Hepatocellular Carcinoma via Enhancing HIF-1α-Dependent Glucose Metabolic Reprogramming.LYRM2通过增强HIF-1α依赖性葡萄糖代谢重编程促进肝细胞癌的生长和转移。
J Cell Mol Med. 2024 Dec;28(23):e70241. doi: 10.1111/jcmm.70241.
7
Installation of LYRM proteins in early eukaryotes to regulate the metabolic capacity of the emerging mitochondrion.早期真核生物中 LYRM 蛋白的安装,以调节新兴线粒体的代谢能力。
Open Biol. 2024 May;14(5):240021. doi: 10.1098/rsob.240021. Epub 2024 May 22.
8
Cysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/ERK axis in esophageal squamous carcinoma cancer.半胱氨酸蛋白酶抑制剂 1 通过介导食管鳞癌细胞的氧化磷酸化/MEK/ERK 轴促进转移。
Sci Rep. 2024 Feb 29;14(1):4985. doi: 10.1038/s41598-024-55544-1.
9
A compendium of mitochondrial molecular characteristics provides novel perspectives on the treatment of rheumatoid arthritis patients.线粒体分子特征纲要为类风湿关节炎患者的治疗提供了新视角。
J Transl Med. 2023 Aug 22;21(1):561. doi: 10.1186/s12967-023-04426-7.
10
Shining a light on the dark proteome: Non-canonical open reading frames and their encoded miniproteins as a new frontier in cancer biology.揭示黑暗蛋白质组的奥秘:非规范开放阅读框及其编码的微小蛋白作为癌症生物学的新前沿。
Protein Sci. 2023 Aug;32(8):e4708. doi: 10.1002/pro.4708.